The NIH announced that it is launching a phase 2 human challenge trial of AV-1, an investigational monoclonal antibody to ...

The trial will see healthy volunteers infected with dengue to test the impact of AbViro’s monoclonal antibody therapy.

The reemergence of dengue virus serotype 3 (DENV-3) in Brazil after 17 years could help worsen fresh outbreaks of the disease ...

Local officials declared Saturday a dengue outbreak in Quezon City amid a steep rise in cases and at least 10 deaths due to ...

Deadly viruses could become endemic in Europe unless urgent measures are taken, a leading expert has warned. Rising global ...

If AV-1 shows promising results in this clinical trial, researchers may pursue further clinical evaluations of its safety and ...

Three species of mosquito are of particular concern in Europe, according to the European Centre for Disease Prevention and ...

Australian antiviral drug development company Island Pharmaceuticals has completed subject dosing for the phase 2b ...

The most common symptoms were muscle pain ... country in the Americas and has long been hyperendemic for all dengue virus serotypes. In recent years, DENV-1 and -2 have been the most common ...